GlobeNewswire Inc.25. aug. 2026, 11.02
Ocugen to Participate in Upcoming September Investor and Industry Conferences
Ocugen, Inc. announced it will present its innovative modifier gene therapy platform at three major conferences in September 2026, including the Citi Biopharma Back to School Conference, H.C. Wainwright Global Investment Conference, and The Retina Society Annual Scientific Meeting. The company will showcase 12-month Phase 2 results for OCU410 gene therapy for geographic atrophy.
